ID   R-3327-AT-2
AC   CVCL_L303
SY   R3327-AT-2; R-3327 AT.2; AT-2; AT2; AT-2-TC; Dunning R3327-AT2
DR   CancerTools; 156411
DR   TKG; TKG 0119
DR   TKG; TKG 0475
DR   Wikidata; Q54948962
DR   Ximbio; 156411
RX   PubMed=3174494;
RX   PubMed=3774632;
RX   PubMed=7910810;
RX   PubMed=23467722;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS:0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_Y658 ! R-3327-H
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 9
//
RX   PubMed=3174494; DOI=10.1002/pros.2990130208;
RA   Isaacs J.T., Hukku B.;
RT   "Nonrandom involvement of chromosome 4 in the progression of rat
RT   prostatic cancer.";
RL   Prostate 13:165-188(1988).
//
RX   PubMed=3774632; DOI=10.1002/pros.2990090306;
RA   Isaacs J.T., Isaacs W.B., Feitz W.F.J., Scheres J.;
RT   "Establishment and characterization of seven Dunning rat prostatic
RT   cancer cell lines and their use in developing methods for predicting
RT   metastatic abilities of prostatic cancers.";
RL   Prostate 9:261-281(1986).
//
RX   PubMed=7910810; DOI=10.1002/ijc.2910570519;
RA   Bashir I., Sikora K., Abel P., Foster C.S.;
RT   "Establishment and in vivo characterization of multidrug-resistant
RT   Dunning R3327 rat prostate-carcinoma cell-lines.";
RL   Int. J. Cancer 57:719-726(1994).
//
RX   PubMed=23467722; DOI=10.3892/or.2013.2323;
RA   Musialik E., Ryszawy D., Madeja Z., Korohoda W.;
RT   "Morpho-physiological heterogeneity of cells within two rat prostate
RT   carcinoma cell lines AT-2 and MAT-LyLu differing in the degree of
RT   malignancy observed by cell cloning and the effects of caffeine,
RT   theophylline and papaverine upon a proportion of the clones.";
RL   Oncol. Rep. 29:1789-1796(2013).
//